Ionsys “Approvable” Letter Brings Alza’s E-Trans System Closer to Market
This article was originally published in The Pink Sheet Daily
Executive Summary
The patient-controlled transdermal fentanyl system for acute pain uses iontophoresis to deliver the opioid across intact skin by applying a low-level ionic current.
You may also be interested in...
J&J/Alza’s Ionsys To Launch In 2007
The fentanyl treatment’s availability waits on completion of a risk management plan despite FDA approval.
J&J/Alza’s Ionsys To Launch In 2007
The fentanyl treatment’s availability waits on completion of a risk management plan despite FDA approval.
Alza Resubmits Ionsys NDA
Alza has resubmitted an NDA for its patient-controlled transdermal analgesic Ionsys (fentanyl), the Johnson & Johnson subsidiary announced Nov. 28